Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Lululemon Athletica Q2 2024 Earnings Highlights: Mixed Results, Challenges in US Business

by Team Lumida
August 30, 2024
in Equities
Reading Time: 7 mins read
A A
0
Lululemon Earnings Preview: What to Expect from the Athleisure Giant

"In front of Lululemon store" by Tiger Mask is licensed under CC BY-NC-ND 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Lululemon Athletica reported mixed Q2 2024 results, with strong international growth offset by challenges in the U.S. women’s business.

Summary

Lululemon’s Q2 2024 performance showed total revenue increasing 7% (8% in constant currency) to $2.4 billion, with earnings per share rising 18% to $3.15. International markets, particularly China, demonstrated robust growth, while the U.S. market faced headwinds. CEO Calvin McDonald stated:

“lululemon remains a strong and healthy brand, and we have shown our ability to responsibly manage the business while seizing the many growth opportunities in front of us.”

Main Themes

  • Guidance: Full-year 2024 revenue guidance revised to $10.375-$10.475 billion, representing 8-9% growth
  • Competition: Focus on product innovation and newness to maintain competitive edge
  • Consumer Demand: Strong international demand, particularly in China; softness in U.S. women’s business
  • New Product Announcements: Upcoming launches in training category and expansion of core franchises
  • Economic Outlook: Cautious approach to Q4 due to shorter holiday shopping season and U.S. election

Insights

Lululemon identified a significant factor impacting the U.S. women’s business: reduced newness in core and seasonal styles. This led to lower conversion rates, particularly in bottoms and online channels. The company is implementing fast-track design capabilities to address this issue and expects to return to historical levels of newness by Spring 2025.

Market Opportunity

Lululemon continues to see substantial growth potential in international markets, particularly in China. The company remains on track to quadruple international revenue from 2021 levels by the end of 2026. In China, Lululemon’s localized approach and unique positioning in wellness are driving strong performance across Tier 1, 2, and 3 cities.

Customer Behaviors

The company observed that existing customers, particularly in the U.S. women’s segment, were visiting stores and e-commerce sites but not converting at expected rates due to a lack of newness in the product assortment. Traffic remained positive across all channels, indicating continued brand strength and customer interest.

Capex

  • Capital expenditures for Q2: $145 million
  • Full-year 2024 capital expenditures expected to be $670-$690 million
  • Investments focused on distribution center projects, store expansions, and technology infrastructure

Industry Insights

Lululemon’s challenges in the U.S. women’s business highlight the importance of continuous product innovation and newness in the athletic apparel industry. The company’s success in international markets, particularly China, suggests significant growth potential for athletic wear brands that can effectively localize their offerings and tap into wellness trends.

Key Metrics

Financial Metrics

  • Q2 Revenue: $2.4 billion (+7% YoY)
  • Earnings per share: $3.15 (+18% YoY)
  • Gross margin: 59.6% (+80 basis points YoY)
  • Operating margin: 22.8% (+110 basis points YoY)

KPIs

  • Total comparable sales: +3% (constant currency)
  • Store sales: +11% YoY
  • Digital sales: +2% YoY
  • International revenue: +29% YoY (+31% constant currency)
  • China mainland revenue: +34% YoY (+37% constant currency)

“We remain on track to quadruple international revenue from 2021 levels by the end of 2026.” – Calvin McDonald, CEO

Competitive Differentiators

  1. Strong international growth, particularly in China
  2. Robust men’s business performance (+11% YoY)
  3. Innovative product pipeline, including new performance fabrics
  4. Localized approach to brand building and community engagement
  5. Successful accessories business with growth potential

Key Risks

  1. Continued softness in U.S. women’s business
  2. Potential impact of shorter holiday shopping season and U.S. election on Q4 performance
  3. Execution risks in addressing product newness issues
  4. Macroeconomic uncertainties in key markets

Analyst Q&A Focus Areas

  1. Revenue growth algorithm for North America post-recovery
  2. Timeline for addressing product newness issues
  3. Inventory management and markdown expectations
  4. Sustainability of growth rates in China
  5. Performance of core products and accessories

Lululemon Summary:

Lululemon faces near-term challenges in its U.S. women’s business but remains confident in its long-term growth strategy. The company’s focus on addressing product newness issues, coupled with strong international performance and a robust men’s business, positions it for potential recovery. Investors should watch for improvements in U.S. women’s conversion rates, the success of upcoming product launches, and continued international expansion, particularly in China.

Tags: EARNINGS
Previous Post

Dell Technologies Q2 2025 Earnings Highlights: Strong Performance Driven by AI Momentum

Next Post

MongoDB Earnings Highlights: Solid Q2 Performance Amid Macro Uncertainties

Recommended For You

Shell Maintains $3.5 Billion Buyback Despite Earnings Decline

by Team Lumida
10 hours ago
low angle photography of Shell gas station at night

Key Takeaways: Powered by lumidawealth.com Earnings Decline: Shell’s Q2 adjusted earnings fell 24% to $4.26 billion from $5.58 billion in the previous quarter but beat analyst expectations of $3.74...

Read more

Unilever Beats Q2 Underlying Sales Expectations, Confirms Full-Year Outlook

by Team Lumida
10 hours ago
Unilever Beats Q2 Underlying Sales Expectations, Confirms Full-Year Outlook

Key Takeaways: Powered by lumidawealth.com Sales Growth: Unilever’s underlying sales rose 3.8% in Q2, surpassing analyst expectations of 3.6%, driven by strong demand across all business segments. Turnover Decline:...

Read more

Porsche Cuts 2025 Guidance Again After $1.27 Billion Tariff Hit

by Team Lumida
1 day ago
running black Porsche sedan

Key Takeaways: Powered by lumidawealth.com Tariff Impact: Porsche took a €400 million ($461.9 million) hit from U.S. import tariffs in H1 2025, opting not to pass costs to customers,...

Read more

UBS Posts Strong Q2 Profit as Market Volatility Boosts Trading Revenue

by Team Lumida
1 day ago
UBS Posts Strong Q2 Profit as Market Volatility Boosts Trading Revenue

Key Takeaways: Powered by lumidawealth.com Profit More Than Doubled: UBS reported a Q2 net profit of $2.395 billion, more than doubling from $1.14 billion a year earlier and beating...

Read more

Adidas Shares Drop After Lower-Than-Expected Q2 Sales and Tariff-Related Uncertainty

by Team Lumida
1 day ago
Adidas logo

Key Takeaways: Powered by lumidawealth.com Sales Miss: Adidas reported Q2 sales of €5.95 billion, up 2.2% year-over-year but below analyst expectations of €6.15 billion. Profit Growth: Net profit rose...

Read more

AstraZeneca Reports Strong Q2 Sales and Profit Boosted by Cancer Drugs

by Team Lumida
3 days ago
AstraZeneca Reports Strong Q2 Sales and Profit Boosted by Cancer Drugs

Key Takeaways: Powered by lumidawealth.com Revenue Growth: AstraZeneca’s Q2 revenue rose 12% to $14.5 billion, surpassing analyst estimates. Earnings: Adjusted earnings per share increased 10% to $2.17, in line...

Read more

Whirlpool Cuts Dividend and Lowers Full-Year Profit Guidance Amid Tariff Pressures

by Team Lumida
3 days ago
Whirlpool Cuts Dividend and Lowers Full-Year Profit Guidance Amid Tariff Pressures

Key Takeaways: Powered by lumidawealth.com Profit Outlook Slashed: Whirlpool lowered its full-year adjusted earnings per share (EPS) guidance to $6-$8 from $10, missing analyst expectations of $8.96. Dividend Cut:...

Read more

Boston Beer Cuts Tariff Impact Estimate as Q2 Profit Rises Despite Volume Decline

by Team Lumida
4 days ago
Boston Beer Cuts Tariff Impact Estimate as Q2 Profit Rises Despite Volume Decline

Key Takeaways: Reduced Tariff Impact: Boston Beer lowered its full-year tariff cost estimate to $15-20 million ($0.96-$1.28 per share) from the previous $20-30 million range, citing more moderate...

Read more

Volkswagen Cuts Outlook After $1.5 Billion Tariff Hit

by Team Lumida
6 days ago
blue and white round b logo

Key Takeaways: Powered by lumidawealth.com Tariff Impact: Volkswagen incurred €1.3 billion $1.5 billion in tariff costs in H1 2025, mainly from new U.S. import duties, forcing the company to...

Read more

Carrefour Shares Jump on Sale of Loss-Making Italian Unit

by Team Lumida
6 days ago
Carrefour Shares Jump on Sale of Loss-Making Italian Unit

Key Takeaways: Powered by lumidawealth.com Strategic Exit: Carrefour is selling its loss-making Italian business to NewPrinces Group, taking a €240 million hit but freeing up resources to focus on...

Read more
Next Post
MongoDB Earnings Highlights: Solid Q2 Performance Amid Macro Uncertainties

MongoDB Earnings Highlights: Solid Q2 Performance Amid Macro Uncertainties

Ulta Beauty Earnings Highlights: Navigating Competitive Pressures Amid Beauty Category Normalization

Ulta Beauty Earnings Highlights: Navigating Competitive Pressures Amid Beauty Category Normalization

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

silver iphone 6 on black surface

Apple’s AI Push Falls Flat as iPhone 16 Sales Disappoint

January 31, 2025

Microsoft Earnings Highlights: Strong Performance Driven by AI and Cloud

August 2, 2024
four round silver-colored and gold-colored Bitcoins

Bitcoin Surges with $2Bn Inflows, Ether Eyes $10K

June 10, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018